Stanford Bio-X Seed Grant leads to first new clinical imaging platform in a quarter-century
A clinical imaging system recently designated by the FDA as a “breakthrough device” uses optical and AI technologies pioneered at Stanford to help diagnose skin cancers in real time. This discovery was launched by a Stanford Bio-X Seed Grant!